2024 Women's Venture Competition
The AIM-HI Accelerator Fund congratulates our 2024 semi-finalists led by four aspiring women scientist-entrepreneurs. The winning early-stage oncology company of 2024 Women’s Venture Competition will be eligible to receive investment from AIM-HI and co-investors, subject to due diligence, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.
Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations.
Our Semi-Finalists
Oriana Papin-Zoghbi
CEO & Co-Founder
Paraskevi Giannakakou, Ph.D.
CSO
Nabanita Nawar, Ph.D.
CEO & Co-Founder
Deborah Charych, Ph.D.
CEO
In addition, the AIM-HI Women’s Venture Competition is looking to name one of our semi-finalists as the People’s Choice Award for Best Pitch. Who will it be? We can’t all be on the official Judging Committee for the Women’s Venture Competition … but we can ALL Cast our Vote!